Analyst Ratings For CONMED Corporation (NASDAQ:CNMD)
Today, Needham & Company LLC reiterated its Buy rating on CONMED Corporation (NASDAQ:CNMD) with a price target of $79.00.
There are 2 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on CONMED Corporation (NASDAQ:CNMD) is Hold with a consensus target price of $79.3333 per share, a potential 18.87% upside.
Some recent analyst ratings include
- 1/23/2019-CONMED Corporation (NASDAQ:CNMD) had its Buy rating reiterated by Needham & Company LLC with a $79.00 price target
- 11/3/2017-CONMED Corporation (NASDAQ:CNMD) had its Hold rating reiterated by KeyCorp
- 11/3/2017-CONMED Corporation (NASDAQ:CNMD) had its Hold rating reiterated by Piper Jaffray Companies with a $46.00 price target
- 4/27/2017-CONMED Corporation (NASDAQ:CNMD) gets downgraded to Neutral by LADENBURG THALM/SH SH with a price target of $48.00
- On 11/6/2018 Heather L Cohen, EVP, bought 900 with an average share price of $68.60 per share and the total transaction amounting to $61,740.00.
- On 9/14/2018 Stanley W Peters III, VP, sold 1,500 with an average share price of $80.43 per share and the total transaction amounting to $120,645.00.
- On 8/31/2018 Peter K Shagory, EVP, sold 2,500 with an average share price of $80.00 per share and the total transaction amounting to $200,000.00.
- On 8/2/2018 Daniel Jonas, EVP, sold 4,000 with an average share price of $79.73 per share and the total transaction amounting to $318,920.00.
- On 6/13/2018 Terence M Berge, VP, sold 673 with an average share price of $73.00 per share and the total transaction amounting to $49,129.00.
- On 5/10/2018 Jo Ann Golden, Director, sold 3,000 with an average share price of $67.62 per share and the total transaction amounting to $202,860.00.
- On 5/7/2018 Jo Ann Golden, Director, sold 3,000 with an average share price of $67.23 per share and the total transaction amounting to $201,690.00.
About CONMED Corporation (NASDAQ:CNMD)
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and uterine manipulator (VCARE) for use in increasing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers general surgery product in the areas of endoscopic technologies, including minimally invasive diagnostic and therapeutic products; critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company's products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.
Recent Trading Activity for CONMED Corporation (NASDAQ:CNMD)
Shares of CONMED Corporation closed the previous trading session at 66,74 +0,100 0,15 % with 67.38 shares trading hands.
